New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
When are opioid prescription limits effective in reducing prescription duration?

When are opioid prescription limits effective in reducing prescription duration?

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainMany states have passed new laws that place restrictions on the duration of first-time opioid prescriptions to help address the opioid
Breakthroughs March 22,2024
When are opioid prescription limits effective in reducing prescription duration?

When are opioid prescription limits effective in reducing prescription duration?

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainMany states have passed new laws that place restrictions on the duration of first-time opioid prescriptions to help address the opioid
Breakthroughs March 22,2024
FDA approves iloprost for severe frostbite

FDA approves iloprost for severe frostbite

by Physician's Briefing StaffAurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for f
Breakthroughs March 22,2024
FDA approves iloprost for severe frostbite

FDA approves iloprost for severe frostbite

by Physician's Briefing StaffAurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for f
Breakthroughs March 22,2024
Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

by Ian Maidment and Hayley Gorton,The ConversationCredit: CC0 Public DomainArecent study reportedthat sildenafil, sold under the brand name Viagra, and other medicines from the same
Neurology March 22,2024
Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

by Ian Maidment and Hayley Gorton,The ConversationCredit: CC0 Public DomainArecent study reportedthat sildenafil, sold under the brand name Viagra, and other medicines from the same
Neurology March 22,2024
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Oncology March 22,2024
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Oncology March 22,2024
Cefepime-taniborbactam superior to meropenem for complicated UTI

Cefepime-taniborbactam superior to meropenem for complicated UTI

by Elana GotkineFor adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, according to a study published in the Feb. 1
Nephrology & Urology March 22,2024
Cefepime-taniborbactam superior to meropenem for complicated UTI

Cefepime-taniborbactam superior to meropenem for complicated UTI

by Elana GotkineFor adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, according to a study published in the Feb. 1
Nephrology & Urology March 22,2024
ADHD drug Zenzedi recalled over pill mixup

ADHD drug Zenzedi recalled over pill mixup

by Robin FosterThe maker of a drug used to treat ADHD and narcolepsy has recalled one lot of the medication after a pill mixup was discovered.The recallnotice, issued by Azurity Pharmaceuticals
Breakthroughs March 22,2024
ADHD drug Zenzedi recalled over pill mixup

ADHD drug Zenzedi recalled over pill mixup

by Robin FosterThe maker of a drug used to treat ADHD and narcolepsy has recalled one lot of the medication after a pill mixup was discovered.The recallnotice, issued by Azurity Pharmaceuticals
Breakthroughs March 22,2024
ADHD drug shortages are affecting patients in the UK—here's why they're happening

ADHD drug shortages are affecting patients in the UK—here's why they're happening

by Liz Breen and Jonathan Silcock,The ConversationCredit: Pixabay/CC0 Public DomainMillions of people in the UK who take drugs for attention deficit hyperactivity disorder (ADHD) are facing diff
Breakthroughs March 22,2024
ADHD drug shortages are affecting patients in the UK—here's why they're happening

ADHD drug shortages are affecting patients in the UK—here's why they're happening

by Liz Breen and Jonathan Silcock,The ConversationCredit: Pixabay/CC0 Public DomainMillions of people in the UK who take drugs for attention deficit hyperactivity disorder (ADHD) are facing diff
Breakthroughs March 22,2024
Treatment with N-acetyl-L-leucine beneficial for Niemann-Pick disease

Treatment with N-acetyl-L-leucine beneficial for Niemann-Pick disease

by Elana GotkineTreatment with N-acetyl-L-leucine (NALL) for 12 weeks yields better neurological status than placebo among patients with genetically confirmed Niemann-Pick disease type C, according to
Neurology March 22,2024
Treatment with N-acetyl-L-leucine beneficial for Niemann-Pick disease

Treatment with N-acetyl-L-leucine beneficial for Niemann-Pick disease

by Elana GotkineTreatment with N-acetyl-L-leucine (NALL) for 12 weeks yields better neurological status than placebo among patients with genetically confirmed Niemann-Pick disease type C, according to
Neurology March 22,2024
Can Ozempic treat depression? Early signs point to yes

Can Ozempic treat depression? Early signs point to yes

by Lisa Jarvis, Bloomberg OpinionCredit: Unsplash/CC0 Public DomainAdd depression to the growing list of chronic diseases that obesity medicines might alleviate. Signs of improved mental health are sh
Psychiatry & Mental Health March 22,2024
Can Ozempic treat depression? Early signs point to yes

Can Ozempic treat depression? Early signs point to yes

by Lisa Jarvis, Bloomberg OpinionCredit: Unsplash/CC0 Public DomainAdd depression to the growing list of chronic diseases that obesity medicines might alleviate. Signs of improved mental health are sh
Psychiatry & Mental Health March 22,2024
12.8 percent of unique prescribers prescribed topical antifungals in 2021

12.8 percent of unique prescribers prescribed topical antifungals in 2021

by Elana GotkineIn 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 m
Oncology March 22,2024
12.8 percent of unique prescribers prescribed topical antifungals in 2021

12.8 percent of unique prescribers prescribed topical antifungals in 2021

by Elana GotkineIn 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 m
Oncology March 22,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com